CaronElizabethRigdenMD

Oncology • Saint Peters, MO

Associate Professor, Internal Medicine, Washington University School of Medicine

Join to view full profile

Dr. Rigden is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Connect with other colleagues in the same hospital or clinic
Search all U.S. specialist profiles and refer a patient
Read the latest clinical news and earn CME/CEU credits

See Dr. Rigden's full profile

Already have an account?

Office
150 Entrance Way
Saint Peters, MO 63376
Phone+1 636-916-9920

Fax+1 636-916-9176
Is this information wrong?

Education & Training

Washington University/B-JH/SLCH ConsortiumFellowship, Hematology and Medical Oncology, 2004 - 2007
Tulane UniversityResidency, Internal Medicine, 2000 - 2003
Tulane University School of MedicineClass of 2000

Certifications & Licensure

MO State Medical License 2004 - 2025
CT State Medical License 2003 - 2004
LA State Medical License 2001 - 2003
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Medical Oncology

Clinical Trials

Biweekly Intraperitoneal Oxaliplatin With Systemic Capecitabine and Bevacizumab for Patients With Peritoneal Carcinomatosis From Appendiceal or Colorectal Cancer Start of enrollment: 2011 May 10
Active, not recruiting
Phase 1
Combining MLN8237 With Nab-Paclitaxel in Patients With Advanced Solid Malignancies Start of enrollment: 2013 May 07
Completed
Phase 1
Levocetirizine + Capecitabine + Bevacizumab for Patients With Refractory Colorectal Cancer Start of enrollment: 2013 Apr 01
Completed
Phase 2
Combination Chemotherapy in Treating Patients With Advanced Stomach, Gastroesophageal, or Esophageal Cancer Start of enrollment: 2013 Nov 08
Completed
Phase 2
Gene Expression and FDG PET/MRI in Evaluating Treatment Response in Patients With Locally Advanced Rectal Cancer Undergoing Chemotherapy and Radiation Therapy Before Surgery Start of enrollment: 2014 Jun 01
Terminated
Phase 1
Join now to see all

Publications & Presentations

PubMed

9 citations
Genomic Complexity Predicts Resistance to Endocrine Therapy and CDK4/6 Inhibition in Hormone Receptor-Positive (HR+)/HER2-Negative Metastatic Breast Cancer.
Andrew A Davis, Jingqin Luo, Tiantian Zheng, Chao Dai, Xiaoxi Dong, Lu Tan, Rama Suresh, Foluso O Ademuyiwa, Caron Rigden, Timothy P Rearden, Katherine Clifton, Kather...> ;Clinical Cancer Research. 2023 May 1
3 citations
A phase II trial of an alternative schedule of palbociclib and embedded serum TK1 analysis.
Jairam Krishnamurthy, Jingqin Luo, Rama Suresh, Foluso Ademuyiwa, Caron Rigden, Timothy Rearden, Katherine Clifton, Katherine Weilbaecher, Ashley Frith, Anna Roshal, P...> ;NPJ Breast Cancer. 2022 Mar 21
21 citations
Immunogenomic profiling and pathological response results from a clinical trial of docetaxel and carboplatin in triple-negative breast cancer
Foluso O. Ademuyiwa, Ina Chen, Jingqin Luo, Mothaffar F. Rimawi, Ian S. Hagemann, Bryan Fisk, Gejae Jeffers, Zachary L. Skidmore, Anamika Basu, Megan Richters, Cynthia...> ;Breast Cancer Research and Treatment. 2021 Jun 26
12 citations
Nanoparticle albumin-bound paclitaxel with cetuximab and carboplatin as first-line therapy for recurrent or metastatic head and neck cancer: A single-arm, multicenter,...
Douglas Adkins, Jessica Ley, Omar Atiq, Steven Francis Powell, William C. Spanos, Mark M. Gitau, Caron Rigden, Kevin Palka, Jingxia Liu, Peter Oppelt> ;Oral Oncology. 2021 Feb 3
2 citations
Mutation profile differences in younger and older patients with advanced breast cancer using circulating tumor DNA (ctDNA)
Katherine Clifton, Jingqin Luo, Yu Tao, Jennifer Saam, Thereasa A. Rich, Anna Roshal, Ashley Frith, Caron Rigden, Foluso O. Ademuyiwa, Katherine N. Weilbaecher, Leonel...> ;Breast Cancer Research and Treatment. 2021 Feb 1
10 citations
FOLFIRINOX for the Treatment of Advanced Gastroesophageal Cancers: A Phase 2 Nonrandomized Clinical Trial
Haeseong Park, Ramon U. Jin, Andrea Wang-Gillam, Rama Suresh, Caron Rigden, Manik Amin, Benjamin R. Tan, Katrina S. Pedersen, Kian-Huat Lim, Nikolaos A. Trikalinos, Ab...> ;JAMA Oncology. 2020 Aug 1
12 citations
Randomized controlled trial of high-dose versus standard-dose vitamin D3 for prevention of aromatase inhibitor-induced arthralgia
Polly A. Niravath, Susan G. Hilsenbeck, Tao Wang, Sao Jiralerspong, Julie R. Nangia, Anne Pavlick, Foluso O. Ademuyiwa, Ashley Frith, Cynthia X. Ma, Haeseong Park, Car...> ;Breast Cancer Research and Treatment. 2019 Jun 19
12 citations
A Phase I Trial of Temsirolimus and Pemetrexed in Patients with Advanced Non-Small Cell Lung Cancer.
Saiama N. Waqar, Maria Q. Baggstrom, Daniel Morgensztern, Kristina Williams, Caron Rigden, Ramaswamy Govindan> ;Chemotherapy. 2016 Jan 19
54 citations
Five Fractions of Radiation Therapy Followed by 4 Cycles of FOLFOX Chemotherapy as Preoperative Treatment for Rectal Cancer
Robert J. Myerson, Benjamin R. Tan, Steven C. Hunt, Jeffrey R. Olsen, Elisa H. Birnbaum, James W. Fleshman, Feng Gao, Lannis Hall, Ira J. Kodner, A. Craig Lockhart, Ma...> ;International Journal of Radiation Oncology, Biology, Physics. 2014 Mar 15
4 citations
Initial versus sequential adjuvant aromatase inhibitor therapy: a review of the current data.
Matthew J. Ellis, Caron Rigden> ;Current Medical Research and Opinion. 2006 Nov 6
Join now to see all

Journal Articles

FOLFIRINOX for the Treatment of Advanced Gastroesophageal Cancers
Haeseong Park, Andrea Wang-Gillam, Caron Rigden, Katrina S Pedersen, Nikolaos A Trikalinos, JAMA Oncology

Authored Content

FOLFIRINOX for the Treatment of Advanced Gastroesophageal CancersMay 2020

Press Mentions

Safety and Efficacy of Zimberelimab (AB122) in Combination with Domvanalimab (AB154) and Etrumadenant (AB928) in Patients with Previously Treated Non-Small Cell Lung CancerMarch 10th, 2021
Defactinib Combined with Pembrolizumab and Gemcitabine in Patients with Advanced CancerApril 18th, 2016